CytoCore raises $1 million from stock offering

By Sheri Kasprzak

New York, April 11 - CytoCore, Inc. said it completed a $1 million private placement of stock.

The terms of the offering could not be determined by press time Tuesday.

Proceeds from the deal will be used for the company's product development plans.

Chicago-based CytoCore is develops cancer screening systems to detect cervical, endometrial or other cancers.

CytoCore's stock advanced 2 cents, or 14.2%, Tuesday to close at $0.177 (OTCBB: MCDG).

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.